Beyond the Antagonism: Self-Labeled Xanthone Inhibitors as Modeled “Two-in-One” Drugs in Cancer Therapy

[Image: see text] Self-labeled inhibitors (SLIs) are promising for creating links, ranging from cancer therapy and metastatic pathways to mechanistic elucidation. In this study, a new category of “two-in-one” fluorescent xanthone inhibitors was developed for the systematic evaluation of anticancer a...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:ACS Omega
Egile Nagusiak: Yu, Fu-Chao, Lin, Xin-Rong, Liu, Zhi-Cheng, Zhang, Ji-Hong, Liu, Fei-Fei, Wu, Wei, Ma, Yu-Lu, Qu, Wen-Wen, Yan, Sheng-Jiao, Lin, Jun
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Chemical Society 2017
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6044579/
https://ncbi.nlm.nih.gov/pubmed/30023617
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsomega.6b00545
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak